中国临床药理学与治疗学 ›› 1998, Vol. 3 ›› Issue (3): 209-211.
王安才
收稿日期:1998-06-12
发布日期:2020-12-02
作者简介:王安才, 男, 硕士, 副主任医师, 副教授。
Received:1998-06-12
Published:2020-12-02
中图分类号:
王安才. β阻滞剂治疗充血性心力衰竭的最新进展[J]. 中国临床药理学与治疗学, 1998, 3(3): 209-211.
| 1 Waagstein F. Efficacy of beta blockers in idiopathic dilated cardiomyopathy andischemic cardiomyopathy. Am J Cardiol, 1997, 80(9B): 45J 2 Doughty RN, Rodgers Sharpe N, e t al. Effects of beta-blocker therapy on mortality in patients with heart failure. A systemic overview of randomized controlled trials. Eur Heart J, 1997, 18: 56 3 CIBIS Investigators and Committees. A randomized trial of β blockade in heart failure: the Cardiac Insufficiency Bisoprolo Study (CIBIS). Circulation, 1994, 90: 1765 4 Packor M, Bristow MR, Cohn JN, et al, The effect of carvedilolon morbidity and mortality in patients with chronic heart failure. N Eng1 J Med, 1996, 334: 1349 5 Colucci WS, Packer M, Bristow M R, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of hart failure. Circulation, 1996, 94(11): 2800 6 Andersson B, Lomsky M, Waagstein F. The link betweenacute hemodynamic adrenergic beta-blockade andlong-term effects in patients with heart failure – a study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol. Eur Heart J, 1993; 14: 1375 7 Gilbert EM, Anderson JL, Deitchman D, et al. Long-term β- blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double blind, randomized study of bucindolol versus placebo. Am J Med, 1970; 88: 223 8 Dasgupta P, Broadhurst P, Lahiri A. The effects of intravenous carvedilol a new multiple action vasodilator beta-blocker, in congestive heart failure. J Cardio vasc pharmacol, 1991; 18(supple 4): S12 9 Bristow MR, O’Connell JB, Gilbert EM, et al, Dose response of chronic β- blocker treatment in heart failure from either idiopathic dilated or ischemic car diomyopathy - Circulation, 1994; 89: 1632 10 AnderssonB, Caidahl K, Dilenarda A, et al. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation, 1996; 94: 673 11 Australia-New Zealand Heart Failure Research Group. Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation, 1995; 92: 212 12 Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet, 1993; 342: 1441 13 Bristow MR. Mechanism of action of beta-blocking agents in heart failure Am J Cardiol, 1997; 80(11A): 26L 14 Eichhorn EJ, Bristow M. Practical guidelines for initiationof beth-adrenergic blockade in patients with chronic heart failure. Am J Cardiol, 1997, 79(6):794 15 Eichhorn EJ, Hjalmarson A. β-blockor treatment for chronic heart failure -he Frog Prince. Circulation, 1994; 90: 2153 16 Yoshikawa T, Port JD, Asono K, et al. Cardiac adrenergic receptor effects of carvedilol. Eur Heart J, 1996; 17(suppl B): 8 17 Feuerstein GZ, Ruffolo RR. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. Eur Heart J, 1996, 17(suppl B): 24 |
| [1] | 陈曦, 李拥军. 活血类中成药在心肌梗死后心脏修复中的作用[J]. 中国临床药理学与治疗学, 2022, 27(6): 680-688. |
| [2] | 徐建飞, 林利. 高血压药物治疗与非药物治疗研究进展[J]. 中国临床药理学与治疗学, 2022, 27(4): 433-441. |
| [3] | 袁真, 陈碧莲. 氯吡格雷临床研究出血事件综述[J]. 中国临床药理学与治疗学, 2021, 26(3): 341-349. |
| [4] | 邢 开, 龚金玉, 罗建权. 噻嗪类利尿剂相关不良反应的药物基因组学研究进展[J]. 中国临床药理学与治疗学, 2021, 26(2): 204-212. |
| [5] | 党翔吉，周 玲，王艺璇，曾 露. 1例慢性肾功能不全患者个体化抗栓药物治疗实践[J]. 中国临床药理学与治疗学, 2017, 22(4): 477-480. |
| [6] | 浦 春, 陶青松，朱 翔，秦明明，武其文，冯 钢. 三种心肌损伤标志物在急性心肌梗死早期诊断中的应用价值[J]. 中国临床药理学与治疗学, 2017, 22(1): 82-86. |
| [7] | 蒋朋利, 吴晶, 孙鹤. 他汀类药物的使用与认知能力下降、糖尿病及癌症之间的关系[J]. 中国临床药理学与治疗学, 2014, 19(10): 1132-1138. |
| [8] | 王盼, 谢珊珊, 郭建军, 卜海之, 陈西敬. 二氢吡啶类钙拮抗剂的吸收、分布、代谢与排泄研究概况[J]. 中国临床药理学与治疗学, 2013, 18(8): 937-943. |
| [9] | 王珍珊, 李玲, 邓晓兰, 李慧, 喻敏, 严谨, 陈本美, 阳国平, 欧阳冬生. 液质联用(LC-MS)法检测特拉唑嗪及应用[J]. 中国临床药理学与治疗学, 2010, 15(5): 530-534. |
| [10] | 张红霞, 吴勇杰, 高明堂. l-(2, 6-二甲基苯氧基)-2-(3, 4-二甲氧基苯乙氨基)丙烷盐酸盐对大鼠离体心脏缺血再灌注损伤的保护作用[J]. 中国临床药理学与治疗学, 2010, 15(2): 160-165. |
| [11] | 王占庆, 王金萍, 许景峰. 硝酸异山梨酯对大鼠心肌后期预适应的诱导作用[J]. 中国临床药理学与治疗学, 2006, 11(12): 1385-1388. |
| [12] | 朱深银, 周远大, 杜冠华. 黄嘌呤氧化还原酶抑制剂研究进展[J]. 中国临床药理学与治疗学, 2006, 11(10): 1081-1086. |
| [13] | 薛浩, 高敏, 刘国树, 汪海. 盐酸埃他卡林对自发性高血压大鼠肾组织细胞外基质降解系统的影响[J]. 中国临床药理学与治疗学, 2006, 11(10): 1122-1128. |
| [14] | 王占庆, 应翔宇, 许景峰. 抗心肌缺血联合用药的实验研究进展[J]. 中国临床药理学与治疗学, 2006, 11(8): 847-850. |
| [15] | 于爽, 余丽梅, 袁牧, 于泓, 吴芹, 石京山. 萘哌地尔衍生物BWYJ 抗前列腺增生的作用[J]. 中国临床药理学与治疗学, 2006, 11(8): 873-877. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
